Norges Bank
INDV icon

Norges Bank’s Indivior Pharmaceuticals INDV Stock Holding History

Norges Bank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,196,814
Closed -$21.6M – 1872
2024
Q3 		$21.6M Sell
2,196,814
-143,188
-6% -$1.68M ﹤0.01% 1209
2024
Q2 		$36.7M Buy
2,340,002
+59,795
+3% +$1.08M 0.01% 1037
2024
Q1 		$48.8M Sell
2,280,207
-103,567
-4% -$1.95M 0.01% 952
2023
Q4 		$36M Hold
2,383,774
– – 0.01% 1058
2023
Q3 		$51.7M Hold
2,383,774
– – 0.01% 820
2023
Q2 		$55.2M Buy
+2,383,774
New +$54.6M 0.01% 806

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return